Skip to main content

Yun-Dae Han

Yonsei University · Medicine

About the Lab

Professor Yun-Dae Han's research lab specializes in translational cancer immunology and molecular diagnostics, with a focus on identifying and validating novel biomarkers for early detection and immunotherapy of colorectal cancer. The lab investigates immune evasion mechanisms in advanced tumors, particularly the role of NK and NKT cells in tumor surveillance, and develops innovative vaccine strategies targeting antigen-presenting cells to restore anti-tumor immunity. Additionally, the lab pioneers non-invasive liquid biopsy approaches using stool and blood DNA methylation markers—especially SDC2 methylation—for early diagnosis and risk stratification of colorectal cancer.

colorectal cancerDNA methylationimmune evasionnon-invasive biomarkercancer immunotherapy

Research Overview

Papers
151
Total Citations
1,958
Papers (5y)
73
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
73total
2022
2023
2024
2025
2026
Citations per year (5y)
310total
20222023202420252026

Selected Papers

15
1
Article|157 citations·2017
IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours
Hyungseok Seo, Insu Jeon, Byung‐Seok Kim, Myung Hwan Park, Eun‐Ah Bae, Boyeong Song, Choong‐Hyun Koh, Kwangsoo Shin, Il‐Kyu Kim, Ki-Young Choi, Taegwon Oh, Jiyoun Min
SJR Q1Nature CommunicationsOA

During cancer immunoediting, loss of major histocompatibility complex class I (MHC-I) in neoplasm contributes to the evasion of tumours from host immune system. Recent studies have demonstrated that most natural killer (NK) cells that are found in advanced cancers are defective, releasing the malignant MHC-I-deficient tumours from NK-cell-dependent immune control. Here, we show that a natural killer T (NKT)-cell-ligand-loaded tumour-antigen expressing antigen-presenting cell (APC)-based vaccine

ImmunologyImmunology and Microbiology
2
Article|155 citations·2019
Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA
Yoon Dae Han, Tae Jeong Oh, Tae‐Ha Chung, Hui Won Jang, Youn Nam Kim, Sungwhan An, Nam Kyu Kim
SJR Q1Clinical EpigeneticsOA

BACKGROUND: Colorectal cancer (CRC) screening can effectively reduce disease-related mortality by detecting CRC at earlier stages. We have previously demonstrated that the presence of SDC2 methylation in stool DNA is significantly associated with the occurrence of CRC regardless of clinical stage. The aim of this study was to evaluate the clinical performance of stool DNA-based SDC2 methylation test for CRC. METHODS: Aberrant SDC2 methylation in stool-derived DNA was measured by linear target en

OncologyMedicine
3
Article|123 citations·2017
Feasibility of quantifying SDC2 methylation in stool DNA for early detection of colorectal cancer
Tae Jeong Oh, Hyun Il Oh, Yang Yei Seo, Dongjun Jeong, Changjin Kim, Hyoun Woo Kang, Yoon Dae Han, Hyun Cheol Chung, Nam Kyu Kim, Sungwhan An
SJR Q1Clinical EpigeneticsOA

Colorectal cancer (CRC) screening is the most efficient strategy to reduce disease-related mortality. Frequent aberrant DNA methylation is known to occur in selected genes and early during CRC development, which has emerged as a new epigenetic biomarker for early detection of CRC. Previously, we reported that we identified that CpG sites of SDC2 were aberrantly methylated in tumor tissues of most CRC patients through comprehensive methylation analysis and demonstrated a high potential of quantif

OncologyMedicine
4
Article|28 citations·2015
Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation
Yoon Dae Han, Woo Ram Kim, Seung Wan Park, Min Soo Cho, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Nam Kyu Kim
SJR Q3MedicineOA

Preoperative chemoradiotherapy (CRT) is the standard of care for patients with stage II and III rectal cancer. This strategy leads to pathologic complete response (pCR) in a significant number of patients. Factors predictive of pCR are currently being extensively investigated. The aim of this study was to analyze clinical factors that might be predictive of pCR.This study was a retrospective analysis of rectal cancer patients from January 2004 through December 2012. A total of 332 stage II and I

OncologyMedicine
5
Article|22 citations·2017
Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis
Yoon Dae Han, Mahdi Hussain Al Bandar, Audrius Dulskas, Min Soo Cho, Hyuk Hur, Byung Soh Min, Kang Young Lee, Nam Kyu Kim
SJR Q2BMC SurgeryOA

BACKGROUND: Ulcerative colitis (UC) harbours a high risk of UC-associated colorectal cancer (UCCC), which is important cause of morbidity and mortality in patients with inflammatory bowel disease. Overall Survival (OS) of patients with UCCC has not been addressed well in the literature. Thus, we compared oncologic outcome of UCCC and sporadic colorectal cancer (SCC) using propensity score matching analysis. METHODS: Propensity score matching was performed for 36 patients, a 1:1 matching method s

GeneticsBiochemistry, Genetics and Molecular Biology
6
Article|14 citations·2017
Safety and Efficacy of Single-Incision Laparoscopic Totally Extraperitoneal Inguinal Hernia Repair: Comparative Study with Conventional Laparoscopic Totally Extraperitoneal Inguinal Hernia Repair
Yoon Dae Han, Seungwan Park, Woo Ram Kim, Se Jin Baek, Hyuk Hur, Byung Soh Min, Nam Kyu Kim
SJR Q2Journal of Laparoendoscopic & Advanced Surgical TechniquesOA

BACKGROUND: Inguinal hernia is a common disease treated with diverse methods. Nowadays, laparoscopic totally extraperitoneal approach is gaining its validity and shows favorable outcomes. However, single-incision laparoscopic surgery is also widening its applicable fields as a new technique. This study aimed to find whether single-incision laparoscopic total extraperitoneal inguinal hernia repair (SILTEP) is applicable compared to conventional laparoscopic total extraperitoneal hernia repair (CL

SurgeryMedicine
7
Article|14 citations·2022
Palliative surgery as a bridge to systemic treatment for malignant bowel obstruction due to peritoneal metastases: A retrospective, case-control study
Azharuddin Razak O, Seung Yoon Yang, Min Soo Cho, Byung Soh Min, Yoon Dae Han
SJR Q2Asian Journal of SurgeryOA

Compared with BSC, surgery is associated with a better OS in patients with MBO due to PM. Surgery should be considered as a bridge to systemic treatment for such patients.

SurgeryMedicine
8
Article|10 citations·2025
Secretory IgA dysfunction underlies poor prognosis in Fusobacterium -infected colorectal cancer
Ilseok Choi, Kyunga Kim, Sang Cheol Kim, Donghwan Park, Ki Taek Nam, Jun Hyung, Seungbyn Baek, Junha Cha, Hye-Yeong Jo, Minsun Jung, Melody Y. Zeng, Irina Matei
SJR Q1Gut MicrobesOA

(Fn) is commonly enriched in colorectal cancer (CRC) and associated with poor outcomes, though its mechanisms remain unclear. Our study investigated how Fn affects the tumor microenvironment through single-cell transcriptomic analyses of 42 CRC patient tissues, comparing Fn-positive and Fn-negative tumors. We discovered that Fn impairs IgA plasma cell development and secretory IgA (sIgA) production by disrupting communication with tumor-associated macrophages. Additional experiments in germ-free

Molecular BiologyBiochemistry, Genetics and Molecular Biology
9
Article|10 citations·2010
Relation of the Expression of Cyclooxygenase-2 in Colorectal Adenomas and Adenocarcinomas to Angiogenesis and Prognosis
Yoon Dae Han, Young Ki Hong, Jung Gu Kang, Yoon Jung Choi, Chan Heun Park
Journal of the Korean society of coloproctologyOA

These results suggest that COX-2 may play an important role in carcinogenesis through interaction with VEGF and EGFR in human colorectal cancer.

PharmacologyMedicine
10
Article|7 citations·2014
SAR target segmentation based on shape prior
Yoon Dae Han, Yuanxiang Li, Wenxian Yu

It's very challenging to interpret the SAR image due to the speckle noise and target's heterogeneity, etc. And the use of image information alone often leads to poor segmentation. However, the introduction of shape prior into the active contours has proved to be very effective to segment the target. In this study, we define the shape of SAR target and introduce it into our active contours. To avoid the irregularity of level set evolution, a novel potential function is introduced to regularize th

Computer Vision and Pattern RecognitionComputer Science
11
Article|5 citations·2021
A case of caecal “PECOMA”
Azharuddin Razak O, Cristopher Varela, Manar Nassr, Mi‐Ae Jang, Yoon Dae Han
SJR Q3International Journal of Surgery Case ReportsOA

INTRODUCTION AND IMPORTANCE: World Health Organization (WHO) defines PEComa as a mesenchymal tumor composed of histologically and immunohistochemically distinctive perivascular epithelioid cells. The symptoms and clinical signs of PEComa patients are nonspecific. Hence, diagnosis is usually difficult. Since it's a rare diagnosis, further research might help in understanding the disease better. CASE PRESENTATION: The patient in this study was an asymptomatic patient, who did colonoscopy as part o

PhysiologyMedicine
12
Article|4 citations·2010
Relation of the Expression of Cyclooxygenase-2 in Colorectal Adenomas and Adenocarcinomas to Angiogenesis and Prognosis
한윤대, 홍영기, 강중구, 최윤정, 박찬흔
http://kmbase.medric.or.kr/Main.aspx?d=KMBASE&m=VIEW&i=0356720100260050339

Purpose: Recent studies have shown that cyclooxygenase (COX)-2 may be involved in tumor growth, invasion and apoptosis in various carcinomas. Vascular endothelial growth factor (VEGF) has a potent angiogenic activity, and COX-2 promotes angiogenesis by modulating angiogenic factors, including VEGF. Endothelial growth factor receptor (EGFR) is considered as a factor of cell growth, maturation and cell death. The current study was designed to investigate the possible roles of COX-2 in colorectal t

13
Article|3 citations·2024
Potential drug interaction after withdrawal of nirmatrelvir-ritonavir in hospitalized patients with COVID-19 infection
Yoon Dae Han, Yi Gou, Jieqiong Liu, Lingyan Yu, Yuhua Zhao, Zhenwei Yu
SJR Q2Journal of Global Antimicrobial ResistanceOA

The prevalence of potential DDI risk after withdrawal of nirmatlevir-ritonavir was high and should be given more attention.

Emergency MedicineMedicine
14
Article|2 citations·2022
Risk of Anorectal Cancer Associated with Benign Anal Inflammatory Diseases: A Retrospective Matched Cohort Study
Wonjeong Chae, Seung Yeon Kang, Sung‐In Jang, Yoon Dae Han
SJR Q2International Journal of Environmental Research and Public HealthOA

PURPOSE: The purpose of our study was to evaluate the relationship between benign anal inflammatory diseases and anorectal cancer and assess its risk factors. METHODS: A retrospective matched cohort study was conducted that included data from 2002 to 2013. The National Health Insurance Service National Sample Cohort data from 2002 to 2013 was used for the study. Of a total study population of 143,884 individuals, 28,110 individuals with anal fissures were assigned to the case group, while 115,77

SurgeryMedicine
15
Article|2 citations·2025
The COVID-19 pandemic and clinical characteristics of colorectal cancer: a multicenter retrospective study
Yoon Dae Han, Sung Uk Bae, Woo Ram Kim, Dae Ro Lim, Chang Woo Kim
SJR Q1Scientific ReportsOA

The spread of COVID-19 has led to numerous hospitals prioritizing case management and to delays in diagnosis and treatment. Consequently, many cancer patients have developed life-threatening complications during the COVID-19 pandemic. The aim of this study was to investigate the impact of COVID-19 pandemic on colorectal cancer (CRC), including its clinical and pathologic characteristics. This multicenter cohort study was performed at six institutions in Korea and included a total of 3871 patient

OncologyMedicine

Research Areas

OncologyPulmonary and Respiratory MedicineSurgeryImmunologyRheumatologyHepatology

Dive deeper into Yun-Dae Han's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.